Media coverage about CIGNA (NYSE:CI) has trended somewhat positive this week, according to Accern. Accern rates the sentiment of media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. CIGNA earned a media sentiment score of 0.20 on Accern’s scale. Accern also assigned news articles about the health services provider an impact score of 46.6118454439587 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
A number of equities research analysts have recently weighed in on the company. Oppenheimer boosted their price target on CIGNA to $237.00 and gave the company an “outperform” rating in a report on Friday, February 2nd. Morgan Stanley boosted their price target on CIGNA to $255.00 and gave the company an “overweight” rating in a report on Friday, February 2nd. Zacks Investment Research upgraded CIGNA from a “hold” rating to a “buy” rating and set a $231.00 price target for the company in a report on Friday, December 22nd. ValuEngine upgraded CIGNA from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Finally, Goldman Sachs Group assumed coverage on CIGNA in a report on Wednesday, January 3rd. They issued a “neutral” rating and a $247.00 price target for the company. Three equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $210.12.
Shares of CIGNA (CI) traded up $0.11 on Wednesday, reaching $195.55. The company had a trading volume of 645,410 shares, compared to its average volume of 1,550,000. The company has a market cap of $48,210.00, a P/E ratio of 21.42, a P/E/G ratio of 1.16 and a beta of 0.44. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.39 and a current ratio of 0.37. CIGNA has a 52-week low of $141.93 and a 52-week high of $227.13.
In other CIGNA news, EVP John M. Murabito sold 6,099 shares of the business’s stock in a transaction on Thursday, January 18th. The stock was sold at an average price of $220.10, for a total transaction of $1,342,389.90. Following the completion of the transaction, the executive vice president now owns 68,026 shares in the company, valued at approximately $14,972,522.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman Isaiah Harris, Jr. sold 212 shares of the business’s stock in a transaction on Monday, December 11th. The stock was sold at an average price of $209.35, for a total value of $44,382.20. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 64,663 shares of company stock valued at $13,329,903. 1.30% of the stock is owned by company insiders.
CIGNA Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.